However, the EBV IgA/VCA titers were at a high level in all of the NPC groups which led to the conclusion that the plasma EBV DNA levels were more sensitive and specific in terms of monitoring the development of NPC when being compared to the antibody levels [19]. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.